Molecular Predictors of Risk and Clinical Outcome in Patients with Bladder Cancer

Contact: Xifeng Wu, M.D., Ph.D.

Number of Enrolled Cancer Patients/Survivors: 2,401
Years of Diagnoses of Enrolled Cancer Patients/Survivors: 1997-present
Approximate Years of Follow-up: 14 years (the longest)
Cancer Sites Represented: Bladder
Biological Specimens Collected: Blood/Blood Fraction
Urine
Treatment Outcome Measures: Physician/Medical Record Reported
  • Symptom Assessment
  • Acute Medical Event
  • Late Medical Event
  • Cancer Recurrence
  • Death
Patient-Reported
  • Symptom Assessment
  • Quality of Life
  • Cancer Recurrence
Co-morbidities at Study Entry: Diabetes
Heart Disease
Pulmonary Disease
Other
Lifestyle Factors: Smoking
Alcohol Use
Diet
Physical Activity
Body Mass Index
Weight Loss/Control
Other
Treatment Data: Surgery
Radiation
Chemotherapy
Hormonal Therapy
Bone Marrow/Stem Cell Transplant
Treatment Data Assessed By: Electronic Record
Chart Abstraction
Patient Reported Questionnaire
Is the study open to collaboration? Yes

Return to Top